Acute Hepatitis Virus Evaluation - II

The Acute Hepatitis Virus Evaluation – II is a comprehensive blood test panel designed to evaluate the most common viral causes of acute hepatitis. It includes markers for Hepatitis A, B, C, and E, helping assess recent or ongoing viral hepatitis infections. The panel measures Hepatitis A IgM, Hepatitis E IgM and IgG, Hepatitis B Surface Antigen (HBsAg), Hepatitis B e Antigen (HBeAg), Hepatitis B e Antibody (Anti-HBe), and Hepatitis C Antibodies. By evaluating multiple viral markers together, the test supports timely diagnosis and assists healthcare providers in identifying the likely cause of liver inflammation.

Who Should Get This Test Done?

This test may be recommended for individuals who:

●     Have symptoms of acute hepatitis, such as jaundice, fatigue, nausea, vomiting, or abdominal discomfort.

●     Show abnormal liver function test results that require further evaluation.

●     Have been exposed to a person with viral hepatitis or have other risk factors for infection.

●     Need comprehensive screening to determine the cause of suspected acute liver inflammation.

●     Are advised by their healthcare provider to undergo evaluation for viral hepatitis.

Why Consider This Test?

Acute hepatitis can be caused by different viruses, and many of them produce similar symptoms. Identifying the exact viral cause is important for appropriate clinical management and follow-up. The Acute Hepatitis Virus Evaluation – II panel combines multiple hepatitis markers into a single profile, providing a broader assessment than individual tests alone. This comprehensive approach helps differentiate between various hepatitis viruses, supports an accurate diagnosis, and guides further investigations and treatment decisions.

More Information

This panel evaluates a combination of viral antigens, antibodies, and immune response markers associated with Hepatitis A, B, C, and E infections. Each marker provides unique information about exposure to or the presence of a specific hepatitis virus. Since different hepatitis viruses affect the liver in different ways, testing them together offers a more complete clinical assessment. The results are interpreted alongside the patient’s symptoms, medical history, liver function tests, imaging findings, and other relevant laboratory investigations.

Other Names

●     Acute Viral Hepatitis Panel – II

●     Acute Hepatitis Evaluation Panel

●     Viral Hepatitis Screening Panel

●     Hepatitis A, B, C & E Profile

●     Comprehensive Acute Hepatitis Panel